These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 22214881)
1. A solid phase assay for topoisomerase I interfacial poisons and catalytic inhibitors. Cyril V; Muller MT Anal Biochem; 2012 Feb; 421(2):607-16. PubMed ID: 22214881 [TBL] [Abstract][Full Text] [Related]
2. [Poisons of DNA topoisomerases I and II]. Charcosset JY; Soues S; Laval F Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of human DNA topoisomerase IB by a cyclometalated gold III compound: analysis on the different steps of the enzyme catalytic cycle. Castelli S; Vassallo O; Katkar P; Che CM; Sun RW; Desideri A Arch Biochem Biophys; 2011 Dec; 516(2):108-12. PubMed ID: 22033340 [TBL] [Abstract][Full Text] [Related]
5. Benzoxazines as new human topoisomerase I inhibitors and potential poisons. Foto E; Özen Ç; Zilifdar F; Tekiner-Gülbaş B; Yıldız İ; Akı-Yalçın E; Diril N; Yalçın İ Daru; 2020 Jun; 28(1):65-73. PubMed ID: 31832989 [TBL] [Abstract][Full Text] [Related]
6. A Fluorescence-Based Assay for Identification of Bacterial Topoisomerase I Poisons. Annamalai T; Cheng B; Keswani N; Tse-Dinh YC Methods Mol Biol; 2018; 1703():259-268. PubMed ID: 29177747 [TBL] [Abstract][Full Text] [Related]
7. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells. Snyder RD Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223 [TBL] [Abstract][Full Text] [Related]
8. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249 [TBL] [Abstract][Full Text] [Related]
9. Scintillation proximity assay for human DNA topoisomerase I using recombinant biotinyl-fusion protein produced in baculovirus-infected insect cells. Lerner CG; Saiki AY Anal Biochem; 1996 Sep; 240(2):185-96. PubMed ID: 8811905 [TBL] [Abstract][Full Text] [Related]
10. Advantages of an optical nanosensor system for the mechanistic analysis of a novel topoisomerase I targeting drug: a case study. Andersen MB; Tesauro C; Gonzalez M; Kristoffersen EL; Alonso C; Rubiales G; Coletta A; Frøhlich R; Stougaard M; Ho YP; Palacios F; Knudsen BR Nanoscale; 2017 Feb; 9(5):1886-1895. PubMed ID: 28094391 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic compounds from Annonaceus species as DNA topoisomerase I poisons. López-Lázaro M; Martín-Cordero C; Bermejo A; Cortes D; Ayuso MJ Anticancer Res; 2001; 21(5):3493-7. PubMed ID: 11848514 [TBL] [Abstract][Full Text] [Related]
12. The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro. Constantinou A; Stoner GD; Mehta R; Rao K; Runyan C; Moon R Nutr Cancer; 1995; 23(2):121-30. PubMed ID: 7644381 [TBL] [Abstract][Full Text] [Related]
13. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs. Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287 [TBL] [Abstract][Full Text] [Related]
14. Cloning and biochemical characterization of Staphylococcus aureus type IA DNA topoisomerase comprised of distinct five domains. Park JE; Kim HI; Park JW; Park JK; Lee JS Arch Biochem Biophys; 2011 Apr; 508(1):78-86. PubMed ID: 21281597 [TBL] [Abstract][Full Text] [Related]
15. Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform. Wessel I; Jensen LH; Jensen PB; Falck J; Rose A; Roerth M; Nitiss JL; Sehested M Cancer Res; 1999 Jul; 59(14):3442-50. PubMed ID: 10416608 [TBL] [Abstract][Full Text] [Related]
16. Topoisomerase I/II inhibition by a novel naphthoquinone containing a modified anthracycline ring system. Kennedy S; DiCesare JC; Sheaff RJ Biochem Biophys Res Commun; 2011 Apr; 408(1):94-8. PubMed ID: 21458415 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles. Singh M; Tandon V Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067 [TBL] [Abstract][Full Text] [Related]
18. The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA. Davies DR; Mushtaq A; Interthal H; Champoux JJ; Hol WG J Mol Biol; 2006 Apr; 357(4):1202-10. PubMed ID: 16487540 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans. Shi W; Marcus SL; Lowary TL Bioorg Med Chem; 2011 Jan; 19(1):603-12. PubMed ID: 21094049 [TBL] [Abstract][Full Text] [Related]
20. Allosteric inhibition of topoisomerase I by pinostrobin: Molecular docking, spectroscopic and topoisomerase I activity studies. Jadaun A; Subbarao N; Dixit A J Photochem Photobiol B; 2017 Feb; 167():299-308. PubMed ID: 28122297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]